Serotonin 5-HT(2A) Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases
- PMID: 20029624
- PMCID: PMC2790184
- DOI: 10.1155/2009/475108
Serotonin 5-HT(2A) Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases
Abstract
There are high levels of comorbidity between neuropsychiatric and cardiovascular disorders. A key molecule central to both cognitive and cardiovascular function is the molecule serotonin. In the brain, serotonin modulates neuronal activity and is actively involved in mediating many cognitive functions and behaviors. In the periphery, serotonin is involved in vasoconstriction, inflammation, and cell growth, among other processes. It is hypothesized that one component of the serotonin system, the 5-HT(2A) receptor, is a common and contributing factor underlying aspects of the comorbidity between neuropsychiatric and cardiovascular disorders. Within the brain this receptor participates in processes such as cognition and working memory, been implicated in effective disorders such as schizophrenia, and mediate the primary effects of hallucinogenic drugs. In the periphery, 5-HT(2A) receptors have been linked to vasoconstriction and hypertension, and to inflammatory processes that can lead to atherosclerosis.
Similar articles
-
Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.Naunyn Schmiedebergs Arch Pharmacol. 2007 Oct;376(1-2):45-63. doi: 10.1007/s00210-007-0179-1. Epub 2007 Aug 17. Naunyn Schmiedebergs Arch Pharmacol. 2007. PMID: 17703282 Review.
-
Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.Behav Brain Res. 2008 Dec 16;195(1):30-8. doi: 10.1016/j.bbr.2007.12.006. Epub 2008 Feb 1. Behav Brain Res. 2008. PMID: 18241938 Review.
-
Chronic treatment of hydroxytryptamine type 2a receptor antagonist sarpogrelate hydrochloride modulates the vasoreactivity of serotonin in experimental rabbit vein grafts.J Vasc Surg. 2009 Sep;50(3):617-25. doi: 10.1016/j.jvs.2009.05.065. J Vasc Surg. 2009. PMID: 19700096
-
A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex.Neuroscience. 2001;105(2):379-92. doi: 10.1016/s0306-4522(01)00199-3. Neuroscience. 2001. PMID: 11672605
-
Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of n-methyl-D-aspartate receptor channels in pyramidal neurons of prefrontal cortex.J Biol Chem. 2008 Jun 20;283(25):17194-204. doi: 10.1074/jbc.M801713200. Epub 2008 Apr 28. J Biol Chem. 2008. PMID: 18442977 Free PMC article.
Cited by
-
Serotonin and blood pressure regulation.Pharmacol Rev. 2012 Apr;64(2):359-88. doi: 10.1124/pr.111.004697. Epub 2012 Mar 8. Pharmacol Rev. 2012. PMID: 22407614 Free PMC article. Review.
-
Activation of 5-HT2 Receptors Reduces Inflammation in Vascular Tissue and Cholesterol Levels in High-Fat Diet-Fed Apolipoprotein E Knockout Mice.Sci Rep. 2019 Sep 17;9(1):13444. doi: 10.1038/s41598-019-49987-0. Sci Rep. 2019. PMID: 31530895 Free PMC article.
-
Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.Pharmaceuticals (Basel). 2021 Nov 24;14(12):1213. doi: 10.3390/ph14121213. Pharmaceuticals (Basel). 2021. PMID: 34959614 Free PMC article. Review.
-
Genetic architecture and candidate genes detected for chicken internal organ weight with a 600 K single nucleotide polymorphism array.Asian-Australas J Anim Sci. 2019 Mar;32(3):341-349. doi: 10.5713/ajas.18.0274. Epub 2018 Jul 26. Asian-Australas J Anim Sci. 2019. PMID: 30056651 Free PMC article.
-
Psychedelics and Anti-inflammatory Activity in Animal Models.Curr Top Behav Neurosci. 2022;56:229-245. doi: 10.1007/7854_2022_367. Curr Top Behav Neurosci. 2022. PMID: 35546383 Review.
References
-
- Jakovljević M, Crnčević Ž, Ljubičić D, Babić D, Topić R, Šarić M. Mental disorders and metabolic syndrome: a fatamorgana or warning reality? Psychiatria Danubina. 2007;19(1-2):76–86. - PubMed
-
- Meyer JM, Stahl SM. The metabolic syndrome and schizophrenia. Acta Psychiatrica Scandinavica. 2009;119(1):4–14. - PubMed
-
- McIntyre RS, Soczynska JK, Konarski JZ, et al. Should depressive syndromes be reclassified as “metabolic syndrome type II”? Annals of Clinical Psychiatry. 2007;19(4):257–264. - PubMed
-
- Goldbacher EM, Matthews KA. Are psychological characteristics related to risk of the metabolic syndrome? A review of the literature. Annals of Behavioral Medicine. 2007;34(3):240–252. - PubMed
-
- Gans RO. The metabolic syndrome, depression, and cardiovascular disease: interrelated conditions that share pathophysiologic mechanisms. Medical Clinics of North America. 2006;90(4):573–591. - PubMed
LinkOut - more resources
Full Text Sources